tiprankstipranks
Trending News
More News >

Individual Brokerage -5489 - New Portfolio

Alexander Valiyaveedan

Individual Brokerage -5489
Individual Investor
Ranked #247,388 out of 819,944 TipRanks' Investors
Success Rate
57%
46 out of 80
profitable transactions
Average Return
18.96%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 9.37%
6-Month Return▲ 69.12%
12-Month Return-
YTD Return▼ 32.55%
Total Return▼ 32.55%

Best Trade

Opened at
Closed at-
Gain▲ 354.55%

Bio

Performance

49.07%0-49.07%
▼ 12.86%
▼ 1.27%
▼ 24.53%
Feb 2025
▼ 1.80%
▼ 5.57%
▼ 49.07%
Mar 2025
▲ 1.84%
▼ 0.87%
▲ 9.85%
Apr 2025
▲ 12.20%
▲ 6.28%
▲ 13.09%
May 2025
▲ 6.24%
▲ 5.14%
▲ 10.26%
Jun 2025
▲ 27.92%
▲ 2.30%
▲ 5.38%
Jul 2025
▲ 4.87%
▲ 2.05%
▲ 11.22%
Aug 2025
▲ 6.53%
▲ 2.77%
▲ 11.91%
Sep 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 12.86%▼ 1.27%▼ 24.53%
▼ 1.80%▼ 5.57%▼ 49.07%
▲ 1.84%▼ 0.87%▲ 9.85%
▲ 12.20%▲ 6.28%▲ 13.09%
▲ 6.24%▲ 5.14%▲ 10.26%
▲ 27.92%▲ 2.30%▲ 5.38%
▲ 4.87%▲ 2.05%▲ 11.22%
▲ 6.53%▲ 2.77%▲ 11.91%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Allegiant Gold
2.42%
▼ 4.29%
2
Sell
Sep 18, 2025
Sayona Mining
0.28%
▲ 4.75%
2
Sell
Sep 13, 2025
Palatin Technologies
▲ 30.28%
4
Close
Sep 12, 2025
Durect
▲ 250.46%
2
Close
Sep 11, 2025
Hdfc Bank
0.01%
▼ 1.94%
2
Sell
Sep 05, 2025
Oxford Lane Capital
16.57%
▼ 8.37%
2
Buy
Sep 05, 2025
Lucid Group
0.82%
▲ 15.85%
4
Buy
Aug 29, 2025
Imunon
0.83%
▼ 20.29%
5
Buy
Aug 21, 2025
B2Gold
▲ 10.53%
2
Close
Aug 08, 2025
ImageneBio
0.12%
▼ 15.65%
4
Buy
Jul 30, 2025
Elevation Oncology
▼ 11.06%
3
Close
Jul 25, 2025
Novo Nordisk
▲ 8.39%
2
Sell
Jul 24, 2025
Tron
0.02%
▼ 26.18%
2
Close
Jul 18, 2025
Chalice Brands
0.01%
0.00%
1
Buy
Jul 16, 2025
Third Bench
0.01%
0.00%
1
Buy
Jul 16, 2025
Blue Sphere
0.92%
0.00%
1
Buy
Jul 16, 2025
Rising Biosciences
1.6%
0.00%
1
Buy
Jul 16, 2025
T2 Biosystems
0%
▼ 88.54%
1
Buy
Jul 16, 2025
CBD Life Sciences
0.01%
0.00%
1
Buy
Jul 16, 2025
Healthier Choices Management
12.23%
0.00%
1
Buy
Jul 16, 2025